10X Genomics Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 10X Genomics Inc 公司

10x Genomics, Inc. 是一家生命科學技術公司。該公司的綜合解決方案包括用於分析生物系統的儀器、耗材和軟件。其 Chromium 平臺包括 Chromium X 系列、Chromium Connect 和傳統 Chromium Controller 儀器、微流控芯片和相關耗材，可實現單個生物成分的通量分析。其 Visium 平臺使研究人員能夠以高分辨率瞭解組織內生物分析物的空間位置。其用於原位分析的 Xenium 平臺旨在讓科學家不僅能夠在組織環境中定位和分類細胞。其產品包括 Chromium 單細胞基因表達、Chromium 單細胞基因表達 Flex、Chromium 單細胞免疫分析、Chromium 單細胞轉座酶可及染色質 (ATAC) 檢測、Chromium 單細胞多組 ATAC + 基因表達、Visium 空間基因表達等。

公司簡介

公司代碼TXG

公司名稱10X Genomics Inc

上市日期Sep 12, 2019

成立日期2012

CEOMr. Serge Wilson Saxonov, Ph.D.

員工數量1306

證券類型Ordinary Share

年結日Sep 12

公司地址6230 Stoneridge Mall Road

城市PLEASANTON

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編94588

電話19254017300

網址https://www.10xgenomics.com/

公司代碼TXG

上市日期Sep 12, 2019

成立日期2012

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Serge Wilson Saxonov, Ph.D.

Chief Executive Officer, Co-Founder, Director

1.07M

-0.09%

Dr. John R. Stuelpnagel

Independent Chairman of the Board

369.61K

+4.34%

Whitaker (Eric S)

Chief Legal Officer

202.20K

+29.09%

Mr. Sridhar (Sri) Kosaraju

Independent Director

59.45K

+34.83%

Dr. Benjamin J. Hindson, Ph.D.

President, Co-Founder, Chief Scientific Officer, Director

52.17K

-12.55%

Ms. Kimberly J. (Kim) Popovits

Independent Director

28.62K

+115.82%

Dr. Shehnaaz Suliman, M.D.

Independent Director

28.62K

+115.82%

Mr. Adam S. Taich

Chief Financial Officer

--

Mr. Alan V. Mateo

Independent Director

--

Dr. Sarah A. Teichmann

Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Serge Wilson Saxonov, Ph.D.

Chief Executive Officer, Co-Founder, Director

1.07M

-0.09%

Dr. John R. Stuelpnagel

Independent Chairman of the Board

369.61K

+4.34%

Whitaker (Eric S)

Chief Legal Officer

202.20K

+29.09%

Mr. Sridhar (Sri) Kosaraju

Independent Director

59.45K

+34.83%

Dr. Benjamin J. Hindson, Ph.D.

President, Co-Founder, Chief Scientific Officer, Director

52.17K

-12.55%

Ms. Kimberly J. (Kim) Popovits

Independent Director

28.62K

+115.82%

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Consumables

115.36M

74.48%

Products and services revenue

17.06M

11.01%

Instruments

14.81M

9.57%

Services

7.65M

4.94%

地區USD

名稱

營收

佔比

United States

86.82M

56.05%

Europe, the Middle East and Africa

31.89M

20.59%

China

16.88M

10.90%

Asia Pacific

15.54M

10.03%

Americas

3.75M

2.42%

業務

地區

業務USD

名稱

營收

佔比

Consumables

115.36M

74.48%

Products and services revenue

17.06M

11.01%

Instruments

14.81M

9.57%

Services

7.65M

4.94%

股東統計

更新時間: 5月23日週五

持股股東

股東類型

持股股東

佔比

ARK Investment Management LLC

11.56%

The Vanguard Group, Inc.

9.99%

Fidelity Management & Research Company LLC

7.72%

Millennium Management LLC

4.98%

BlackRock Institutional Trust Company, N.A.

4.87%

Other

60.88%

持股股東

佔比

ARK Investment Management LLC

11.56%

The Vanguard Group, Inc.

9.99%

Fidelity Management & Research Company LLC

7.72%

Millennium Management LLC

4.98%

BlackRock Institutional Trust Company, N.A.

4.87%

Other

60.88%

股東類型

持股股東

佔比

Investment Advisor

45.04%

Investment Advisor/Hedge Fund

22.18%

Hedge Fund

19.03%

Bank and Trust

5.32%

Research Firm

5.16%

Venture Capital

3.69%

Individual Investor

1.92%

Pension Fund

0.68%

Family Office

0.30%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

656

115.46M

103.93%

-12.51M

2025Q1

687

115.67M

104.27%

-8.84M

2024Q4

689

107.08M

98.92%

-12.41M

2024Q3

682

106.90M

100.39%

-9.08M

2024Q2

691

105.36M

99.70%

-5.09M

2024Q1

762

106.36M

101.17%

-3.12M

2023Q4

817

100.80M

96.01%

-9.73M

2023Q3

835

96.86M

93.80%

-12.55M

2023Q2

857

94.98M

96.77%

-15.37M

2023Q1

864

95.62M

97.55%

-9.91M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

ARK Investment Management LLC

12.85M

11.56%

+901.66K

+7.55%

Mar 31, 2025

The Vanguard Group, Inc.

11.09M

9.99%

+184.54K

+1.69%

Mar 31, 2025

Fidelity Management & Research Company LLC

8.58M

7.72%

-2.75M

-24.30%

Mar 31, 2025

Millennium Management LLC

5.53M

4.98%

+156.13K

+2.90%

Apr 01, 2025

BlackRock Institutional Trust Company, N.A.

5.41M

4.87%

-108.37K

-1.96%

Mar 31, 2025

Sumitomo Mitsui Trust Bank, Limited

5.36M

4.83%

+5.36M

--

Mar 31, 2025

UBS Asset Management (Switzerland)

4.10M

3.69%

+2.13M

+108.14%

Mar 31, 2025

Two Sigma Investments, LP

3.17M

2.85%

+614.32K

+24.04%

Mar 31, 2025

UBS Asset Management (Americas) LLC

2.90M

2.61%

+2.85M

+4.95K%

Mar 31, 2025

BofA Global Research (US)

2.56M

2.3%

+2.03M

+386.97%

Mar 31, 2025

持股ETF

更新時間: 7月6日週日

機構名稱

佔比

ARK Genomic Revolution ETF

3.47%

ARK Innovation ETF

1.55%

WisdomTree BioRevolution Fund

1.48%

Global X Genomics & Biotechnology ETF

1.35%

Invesco NASDAQ Future Gen 200 ETF

0.54%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.36%

ProShares Ultra Nasdaq Biotechnology

0.15%

Invesco Nasdaq Biotechnology ETF

0.11%

iShares Biotechnology ETF

0.1%

Goldman Sachs Innovate Equity ETF

0.08%

ARK Genomic Revolution ETF

佔比3.47%

ARK Innovation ETF

佔比1.55%

WisdomTree BioRevolution Fund

佔比1.48%

Global X Genomics & Biotechnology ETF

佔比1.35%

Invesco NASDAQ Future Gen 200 ETF

佔比0.54%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比0.36%

ProShares Ultra Nasdaq Biotechnology

佔比0.15%

Invesco Nasdaq Biotechnology ETF

佔比0.11%

iShares Biotechnology ETF

佔比0.1%

Goldman Sachs Innovate Equity ETF

佔比0.08%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

10X Genomics Inc

11.920USD

10X Genomics Inc

11.920

概覽

公司